Roxicet and Transderm scop drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Roxicet (acetaminophen; oxycodone hydrochloride) and Transderm scop (scopolamine). Common drug interactions include amnesia among females.
The phase IV clinical study analyzes what interactions people have when they take Roxicet and Transderm scop. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Roxicet?
Roxicet has active ingredients of acetaminophen; oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 2,254 Roxicet users. Check the latest studies of Roxicet.
What is Transderm scop?
Transderm scop has active ingredients of scopolamine. It is often used in motion sickness. eHealthMe is studying from 3,011 Transderm scop users. Check the latest studies of Transderm scop.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
11 people who take Roxicet and Transderm scop together, and have interactions are studied.

What are the common drug interactions of Roxicet and Transderm Scop, by gender? *:
female:
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Chills (felling of cold)
- Hypoaesthesia (reduced sense of touch or sensation)
- Intervertebral disc protrusion (spinal disc protrusion)
- Malaise (a feeling of general discomfort or uneasiness)
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Therapeutic response unexpected
- Ventricular extrasystoles (premature cardiac contraction)
- Blood pressure increased
- Chronic kidney disease
male:
n/a
What are the common drug interactions of Roxicet and Transderm Scop, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Chills (felling of cold)
- Crying
- Dehydration (dryness resulting from the removal of water)
- Diarrhoea
- Incoherent (talking in a confused and unclear way)
- Pyrexia (fever)
- Tremor (trembling or shaking movements in one or more parts of your body)
- Vomiting
- Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
60+:
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Chills (felling of cold)
- Vomiting
- Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
- Crying
- Dehydration (dryness resulting from the removal of water)
- Diarrhoea
- Incoherent (talking in a confused and unclear way)
- Malaise (a feeling of general discomfort or uneasiness)
- Muscular weakness (muscle weakness)
What are the existing conditions these people have? *
- Insomnia (sleeplessness): 5 people, 45.45%
- Fibromyalgia (a long-term condition which causes pain all over the body): 5 people, 45.45%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 45.45%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 45.45%
- Gout (uric acid crystals building up in the body): 1 person, 9.09%
- Eye Swelling: 1 person, 9.09%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 9.09%
- Fungal Infection: 1 person, 9.09%
- Fungal Skin Infection: 1 person, 9.09%
- Gastric Ulcer (stomach ulcer): 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Roxicet and Transderm scop?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Roxicet (2,254 reports)
- Transderm scop (3,011 reports)
Browse all drug interactions of Roxicet and Transderm scop:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Roxicet:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Transderm scop:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Roxicet and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Transderm scop and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on acetaminophen; oxycodone hydrochloride and scopolamine (the active ingredients of Roxicet and Transderm scop, respectively), and Roxicet and Transderm scop (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ativan cause Orthostatic Hypotension? - a second ago
- Cellcept and Renal Failure Acute for Girls aged 10-19 - 6 seconds ago
- Cellcept and Renal Failure for Girls aged 10-19 - 7 seconds ago
- Cellcept and Kidney Failure for Girls aged 10-19 - 7 seconds ago
- Cellcept and Arf for Girls aged 10-19 - 7 seconds ago
- Cellcept and Acute Kidney Failure for Girls aged 10-19 - 8 seconds ago
- Anxiety Aggravated and Oral Disorder - 9 seconds ago
- Drug interactions of Pradaxa and Colace - 10 seconds ago
- Could Forteo cause Injection Site Pain? - 13 seconds ago
- Aldactone and Pancreatitis Aggravated for Men aged 60+ - 13 seconds ago